Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC052484 Inhibitors

Chemical inhibitors of BC052484 can exert their inhibitory action through various mechanisms, primarily by disrupting the STAT3 signaling pathway, which is crucial for the function of BC052484. STA-21, S3I-201, Cryptotanshinone, AG490, WP1066, SD-1029, SH-4-54, Stattic, BP-1-102, and C188-9 are chemicals that directly or indirectly target components of the STAT3 pathway. STA-21 disrupts STAT3 dimerization, which is essential for its transcriptional activity. In a similar vein, S3I-201 and Cryptotanshinone inhibit STAT3 phosphorylation, thereby preventing its activation and subsequent downstream effects on BC052484. AG490 targets this pathway further upstream, by inhibiting JAK2 kinase, which is responsible for the initial phosphorylation and activation of STAT3. This results in reduced STAT3 phosphorylation, subsequently leading to decreased activity of BC052484. WP1066 and SD-1029 also block STAT3 phosphorylation, with WP1066 additionally preventing its nuclear translocation, thus impeding the transcriptional activity that would otherwise promote BC052484 activity.

In contrast, SH-4-54, Stattic, and BP-1-102 bind directly to STAT3, inhibiting its phosphorylation, dimerization, and DNA binding capabilities. This direct binding results in a significant reduction of STAT3's transcriptional activity, thereby inhibiting the activity of BC052484, which is regulated by STAT3-mediated transcription. Meanwhile, Niclosamide works by uncoupling mitochondrial oxidative phosphorylation, leading to a decrease in ATP levels, which are vital for energy-dependent processes including those involving BC052484. Pyrimethamine takes a different approach by inhibiting dihydrofolate reductase, an enzyme critical for thymidine synthesis, which is necessary for DNA synthesis-dependent processes, thus affecting the activity of BC052484. This array of chemicals demonstrates various strategies by which the activity of BC052484 can be inhibited, each targeting different aspects of the cellular processes and signaling pathways that regulate BC052484's function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Stat3 Inhibitor VI, S3I-201

501919-59-1sc-204304
10 mg
$151.00
104
(1)

S3I-201 inhibits STAT3 phosphorylation and subsequent activation, impacting the STAT3-dependent functions of BC052484.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$38.00
$79.00
$188.00
$520.00
$1248.00
$5930.00
8
(1)

Niclosamide uncouples mitochondrial oxidative phosphorylation, which can decrease ATP levels, thereby inhibiting energy-dependent processes including those involving BC052484.

Cryptotanshinone

35825-57-1sc-280649
10 mg
$119.00
1
(1)

Cryptotanshinone selectively inhibits STAT3 phosphorylation and activation, affecting the activity of BC052484 which operates downstream of STAT3.

Tyrphostin B42

133550-30-8sc-3556
5 mg
$26.00
4
(1)

AG490 inhibits JAK2 kinase, which is upstream of STAT3 signaling, resulting in reduced STAT3 phosphorylation and inhibition of BC052484 activity.

Stat3 Inhibitor III, WP1066

857064-38-1sc-203282
10 mg
$132.00
72
(1)

WP1066 blocks STAT3 phosphorylation and nuclear translocation, impacting STAT3-mediated transcriptional activity, indirectly inhibiting BC052484.

Stat3 inhibitor V, stattic

19983-44-9sc-202818
sc-202818A
sc-202818B
sc-202818C
sc-202818D
sc-202818E
sc-202818F
25 mg
100 mg
250 mg
500 mg
1 g
2.5 g
5 g
$130.00
$196.00
$274.00
$512.00
$731.00
$1408.00
$2091.00
114
(3)

Stattic selectively inhibits STAT3 activation, dimerization, and nuclear translocation, thereby inhibiting the STAT3-dependent activity of BC052484.

Pyrimethamine

58-14-0sc-208190
sc-208190A
sc-208190B
1 g
5 g
25 g
$80.00
$238.00
$825.00
5
(0)

Pyrimethamine inhibits dihydrofolate reductase, which can affect thymidine synthesis, and therefore, impact DNA synthesis-dependent processes of BC052484.

A 83-01

909910-43-6sc-203791
sc-203791A
10 mg
50 mg
$202.00
$811.00
16
(1)

BP-1-102 binds to STAT3, disrupting STAT3-DNA binding and transcriptional activity, which is necessary for the functional activity of BC052484.